<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001738061</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001723128</issuerCik>
      <issuerName>Amneal Pharmaceuticals, Inc.</issuerName>
      <secFileNumber>001-38485</secFileNumber>
      <issuerAddress>
        <com:street1>400 Crossing Boulevard</com:street1>
        <com:city>Bridgewater</com:city>
        <com:stateOrCountry>NJ</com:stateOrCountry>
        <com:zipCode>08807</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(908) 947-3120</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Shah Nikita</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Charles Schwab Corp</name>
        <address>
          <com:street1>3000 Schwab Way</com:street1>
          <com:city>Westlake</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76262</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>30000</noOfUnitsSold>
      <aggregateMarketValue>235800.00</aggregateMarketValue>
      <noOfUnitsOutstanding>309542608</noOfUnitsOutstanding>
      <approxSaleDate>08/14/2024</approxSaleDate>
      <securitiesExchangeName>Nasdaq</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>07/05/2018</acquiredDate>
      <natureOfAcquisitionTransaction>Employee Compensation</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>30000</amountOfSecuritiesAcquired>
      <paymentDate>07/05/2018</paymentDate>
      <natureOfPayment>Equity Compensation</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>08/14/2024</noticeDate>
      <signature>Nikita Shah</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2719}]
144
0001738061
XXXXXXXX
LIVE
0001723128
Amneal Pharmaceuticals, Inc.
001-38485
400 Crossing Boulevard
Bridgewater
NJ
08807
(908) 947-3120
Shah Nikita
Officer
Common
Charles Schwab Corp
3000 Schwab Way
Westlake
TX
76262
30000
235800.00
309542608
08/14/2024
Nasdaq
Common
07/05/2018
Employee Compensation
Issuer
N
30000
07/05/2018
Equity Compensation
Y
08/14/2024
Nikita Shah